Legal & Regulatory

CBD Decree Suspended By Italian Administrative Court for Third Time

Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending a final ruling in December. This marks the third suspension of the decree to date. The European Court of Justice has also previously ruled CBD and hemp extracts as legal within the EU, and recent ECJ cases reaffirmed member states cannot impose similar restrictions on CBD.

For the third time, Italy’s Regional Administrative Court (TAR) of Lazio has ruled to suspend a Ministry of Health decree that classified oral compositions containing CBD as “narcotic” substances.

After hearing an appeal by ICI-Imprenditori Canapa Italia, the judges accepted the request for suspension brought forth by Sviluppo Srl. The court also confirmed that a hearing scheduled for December 16 will address the merits of all filed appeals against the CBD order.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Court’s September CBD Ruling Supports Suspension Decision

The TAR’s recent ruling on CBD echoes its decision from September 11, which upheld a similar suspension request against the government measure.

The court stated, “In full agreement with the previous judgment, the conditions for accepting the proposed conservatory request are also present in this case, affirming the December 16, 2024, public hearing for the joint consideration of the appeals related to this case.”

Italy’s Hemp and CBD Industry Faces Major Challenge

Italy’s hemp and CBD industry is likely facing its most significant challenge yet. Beyond pursuing justice domestically, Italian industry leaders are also seeking support from Europe in hopes of solidifying their rights.

Canapa Sativa Italia, a trade group representing the Italian hemp and CBD industry, has filed an official complaint with the European Commission (EC), arguing that Italy’s actions violate the EU’s Common Agricultural Policy and threaten fair competition within the European market.

European Court of Justice Supports Legal Status of CBD Extracts

The European Court of Justice (ECJ) previously ruled in 2021 that CBD extracts, including leaves and flowers, should not be classified as narcotics. The ECJ emphasized that all extracts, including CBD, are legal and marketable within the EU.

In a more recent decision, the ECJ reaffirmed that “no Member State may enact prohibitive measures beyond what is strictly necessary to protect public health.”

ECJ Case Involving Biohemp Concept Sets Precedent for European Hemp Businesses

A recent case involving Biohemp Concept, a company that was barred by Romanian authorities from growing CBD containing hemp indoors and hydroponically, further supported the rights of hemp businesses. The ECJ’s ruling not only favored the company but also established a precedent for all European hemp enterprises, affirming their right to pursue similar cultivation practices.

(Featured image by Sora Shimazaki via Pexels)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

J. Frank Sigerson

J. Frank Sigerson is a business and financial journalist primarily covering crypto, cannabis, crowdfunding, technology, and marketing. He also writes about the movers and shakers in the stock market, especially in biotech, healthcare, mining, and blockchain. In the past, he has shared his thoughts on IT and design, social media, pop culture, food and wine, TV, film, and music. His works have been published in Investing.com, Equities.com, Seeking Alpha, Mogul, Small Cap Network, CNN, Technology.org, among others.

Recent Posts

Brazil — Supreme Court Legalizes the Cultivation, Processing, and Sale of Hemp for Medical Purposes

The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…

1 hour ago

Why Medical Cannabis in Poland Was Classified in the Same Group as Heroin and Fentanyl

Poland has classified medical cannabis as a high-risk substance (Group I-N) alongside heroin and fentanyl.…

1 day ago

Australian Senate Rejects Bill to Legalize Cannabis

The Australian Senate has rejected the Legalising Cannabis Bill 2023, which proposed a national framework…

5 days ago

Fijian Medical Cannabis Legalization Advances

The Fijian government is drafting legislation after public consultations to establish a transparent, inclusive framework…

1 week ago

Chronic Pain Is the Most Common Reason for Medical Cannabis Use

A Leafwell study found chronic pain as the top condition treated with medical cannabis, although…

1 week ago

Women Represent 61% of Home Cannabis Growers in the U.S.

A survey found that women comprise 61% of home cannabis growers, marking a diversion from…

2 weeks ago